# Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa

> **NCT02695212** · PHASE2 · COMPLETED · sponsor: **Florida Academic Dermatology Centers** · enrollment: 20 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Apremilast

## Key facts

- **NCT ID:** NCT02695212
- **Lead sponsor:** Florida Academic Dermatology Centers
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02695212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02695212, "Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02695212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*